In human, cyclins and CDK also control cell cycle progression.
Polo-like kinases (PLKs) are basically serine/threonine kinase enzymes that control cell cycle from yeast to humans.
E2F proteins control cell cycle progression by predominantly acting as either activators or repressors of transcription [1].
Cyclins, CDKs and cyclin-dependent kinase inhibitors (CKIs) are cell cycle regulatory proteins that control cell cycle transition from one phase to another (G1, S and G2).
These pathways include growth factor‐induced signal transduction routes and processes that control cell cycle progression, such as the p16‐CDK4‐RB and the ARF‐MDM2‐p53 pathways.
The small GTPase Rac1 is involved in the regulation of critical cellular functions, such as transcription control, cell cycle, and organization of actin cytoskeleton.
And, Plas explains, similar to the way current therapies attack signaling pathways that control cell cycle and metastasis, targeting the regulation of metabolism signaling pathways has the potential to serve as an avenue for cancer treatments.
Dysregulation of genes that control cell cycle progression is a hallmark of tumorigenesis.
Some proteins related to Cyclins, RB, and p53, are checkpoints that control cell cycle progression of UM [20].
In addition, as suggested for other centrosome or cilia-associated proteins, βarrs appear to control cell cycle progression.
The same molecules interact in mammalian cells to control cell cycle progression, thus it appears that the same pathway can regulate mutually exclusive processes.
